0
Reviews
Keeping Up-to-Date on Immunizations: A Framework and Review for Pharmacists
Sharon Gatewood, PharmD; Jean-Venable R. Goode, PharmD, BCPS, FAPhA; Dennis Stanley, BPharm
J Am Pharm Assoc (2003) 2006;46:183-192. doi:10.1331/154434506776180685

Abstract

Objective  To provide a framework for keeping current in the immunizations field; an update on changes in adult and pediatric vaccine delivery since 2003; and an update on new immunization guidelines, new approved vaccines, and changes in uses for current vaccines.

Data Sources  Published guidelines identified from the Centers for Disease Control National Immunization Program Web site. In addition, published articles were identified through Medline (January 2003–November 2005) using specific vaccine names as search terms. Additional sources were identified from the bibliographies of retrieved articles.

Study Selection  By the authors.

Data Extraction  By the authors.

Data Synthesis  To implement the immunization services now permitted under law in 44 states, many pharmacists receive initial training through the American Pharmacists Association Pharmacy—Based Immunization Delivery Certificate Program. To remain up-to-date in this field, pharmacists can apply the process described in this article, which includes regular monitoring of the Web site and publications of the Centers for Disease Control and Prevention and participation in one or more listservs. Specific information is presented on new vaccines marketed in the United States since 2003 along with updates on standards for adult and adolescent immunizations and changes in guidelines during this time frame.

Conclusion  As increasingly committed health professionals in the immunizations field, pharmacists are responsible for keeping updated on the constantly changing recommendations for vaccines and related products. By incorporating the recent information presented in this article and applying the process described for tracking changes in this field, pharmacists can fulfill their emerging vaccine-related roles on the health care team.

Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.

OR

Register for a FREE limited account to benefit from personalization features such as alerts.

References

 American Pharmacists Association Web site. Fact sheet as of September 22, 2004. States where pharmacists have the authority to immunize patients. Accessed at www.aphanet.org/pharmcare/ immunofact.html, November 30,  2005.
 
 American Pharmacists Association Web site. Pharmacy-based immunization delivery. A certificate training program for pharmacists. Accessed at www.aphanet.org/pharmcare/ProgramDescriptionOverview.pdf, November  2005.
 
 Influenza virus vaccine live, intranasal. FluMist 2005–2006 formula [package insert]. Accessed at www.flumist.com/pdf/prescribinginfo.pdf, February 13,  2006.
 
Belshe RB, Nichol KL, Black SB, et al. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5–49 years.  Clin Infect Dis.  2004;39:920–7.[PubMed][CrossRef]
 
McCarthy MW, Kockler DR.  Trivalent intranasal influenza vaccine, live.  Ann Pharmacother.  2004;38:2086–93.[PubMed]
 
 Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR Morb Mortal Wkly Rep.  2005;54:1–40.[PubMed]
 
Grabenstein JD.  ImmunoFacts. Vaccines and immunologic drugs. St. Louis:  Wolters Kluwer Health Inc.;  2006.
 
 Meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine. Menactra [product labeling]. Swiftwater, Pa.:  Aventis Pasteur; October  2005.
 
 Centers for Disease Control and Prevention. Prevention and control of meningococcal disease.  MMWR Morb Mortal Wkly Rep.  2005;54:1–21.[PubMed]
 
 Center for Biologics Evaluation and Research, Food and Drug Administration, Immunization Safety Office; National Immunization Program; National Center for Infectious Diseases, Centers for Disease Control and Prevention. Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine—United States, June 2005 MMWR Morb Mortal Wkly Rep. 2005;54:1023–5.[PubMed]
 
 Boosterix (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis, adsorbed [product information]). Rixensart, Belgium:  GlaxoSmithKline. Accessed at www.fda.gov/cber/label/tdapgla050305LB.pdf, November 30,  2005.
 
 Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis, adsorbed. Adacel. Product Information. Swiftwater, Pa.:  Aventis Pasteur. Accessed at www.fda.gov/cber/label/tdappave060105LB.pdf, November 30,  2005.
 
Skowronski DM, Pielak K, Remple VP, et al. Adult tetanus, diphtheria and pertussis immunization: Knowledge, beliefs, behavior and anticipated uptake.  Vaccine.  2004;23:353–61.[PubMed]
 
 ProQuad (measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live [product information]. Whitehouse Station, N.J.:  Merck & Co., Inc.;  2005.
 
Poland GA, Shefer AM, McCauley M, et al. Standards for adult immunization practices.  Am J Prev Med.  2003;25:144–55.[PubMed]
 
 U.S. Department of Health and Human Services. Healthy People 2010. Conference ed. in 2 vols. Washington D.C.:  U.S. Department of Health and Human Services;  2000. Accessed at www.health.gov/healthypeople/document/tableorcontents.htm, November 30,  2005.
 
Steyer TE, Ragucci KR, Pearson WS, et al. The role of pharmacists in the delivery of influenza vaccinations.  Vaccine.  2004;22:1001–6.[PubMed]
 
 Centers for Disease Control and Prevention. Recommended adult immunization schedule—United States, October 2005–September 2006 MMWR Morb Mortal Wkly Rep. 2005;54:Q1–Q4.
 
 Advisory Committee on Immunization Practices recommends adult vaccination with new tetanus, diphtheria, and pertussis vaccine (Tdap) [media release]November 9,  2005. Accessed at www.cdc.gov/od/oc/media/pressrel/r051109.htm, November 30,  2005.
 
 Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR Morb Mortal Wkly Rep.  2004;53:1–40.
 
 CDC's Advisory Committee on Immunization Practices expands hepatitis A vaccination for children [media release]October 28,  2005. Accessed at www.cdc.gov/od/oc/media/pressrel/r051028.htm, November 30,  2005.
 
 Advisory Committee on Immunization Practices votes to recommend routine use of combined tetanus, diphtheria and pertussis (Tdap) vaccines for adolescents. Accessed at www.cdc.gov/nip/vaccine/tdap/tdap_acip-recs.pdf, November 30,  2005.
 
 Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR Morb Mortal Wkly Rep.  2003;52:1–36.
 
 Tiered use of inactivated influenza vaccine in the event of a vaccine shortage MMWR Morb Mortal Wkly Rep. 2005;54:749–50.[PubMed]
 
 Prevention of varicella—provisional updated ACIP recommendations for varicella use. Accessed at www.cdc.gov/nip/vaccine/varicella/varicella_acip-recs.pdf, November 30,  2005.
 
Harper D, Franco E, Cosette W, et al. Efficacy of bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus 16 and 18 in young women: A randomized controlled trial.  Lancet.  2004;364:1757–65.[PubMed]
 
Villa L, Costa R, Petta C, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomized double-blind placebo-controlled multicenter phase II efficacy trial.  Lancet Oncol.  2005;6:271–8.[PubMed]
 
Oxman MN, Levin MJ, Johnson GR, Schmader KE, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.  N Engl J Med.  2005;352:2271–84.[PubMed]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
Advertisement
 
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints